The Union government told Parliament that no conclusive data directly links higher AQI levels to lung diseases, though air pollution triggers respiratory ailments. It highlighted health awareness programmes, early warning systems, and initiatives like Ujjwala and Swachh Bharat to mitigate pollution-related risks.
Novo Nordisk has launched its once-weekly diabetes and weight-management drug Ozempic in India. The semaglutide-based GLP-1 agonist improves glycaemic control, supports weight loss and may reduce cardiovascular and kidney risks. Prices start at Rs 8,800 per month for the lowest dose
